Scrip Dividend Declaration

RNS Number : 1737R

The MedicX Fund Limited

09 September 2014

 



For immediate release

9 September 2014

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Scrip Dividend Declaration

MedicX Fund (LSE: MXF) announces that, pursuant to its scrip dividend scheme (the "Scrip Dividend Alternative"), 727,962 ordinary shares of no par value in the Company ("Shares") will be sold out of treasury by the Company on 30 September 2014 to shareholders who elected to participate in the Scrip Dividend Alternative. Electing shareholders will receive the Shares in lieu of receiving cash for the September 2014 dividend in respect of the quarter ended 30 June 2014.

Elections pursuant to the Scrip Dividend Alternative were received in respect of 11.8 per cent. of the ordinary shares in issue as at the record date of 15 August 2014. The Shares will rank pari passu with the existing ordinary shares.

Following the transaction, the Company will have 361,445,780 ordinary shares in issue, of which 7,056,692 will be held in treasury.  Accordingly the total voting rights in issue will be 354,389,088.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

End

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity                                                           [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan Communications                                              [phone]

Charles Ryland/Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 136 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement. 

 

END

 

 

MSCKKLBBZKFFBBZ